BLMH:OTC-Blum Holdings Inc (USD)

COMMON STOCK | Pharmaceutical Retailers |

Last Closing

USD 0.65

Change

-0.05 (-7.12)%

Market Cap

USD 0.01B

Volume

326.00

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-06-02 )

Largest Industry Peers for Pharmaceutical Retailers

Symbol Name Price(Change) Market Cap
JDHIY JD Health International Inc

N/A

USD 16.82B
ALBHF Alibaba Health Information Tec..

N/A

USD 10.86B
JDHIF JD Health International Inc

N/A

USD 10.33B
CLCGY Clicks Group Ltd

-0.99 (-2.30%)

USD 5.14B
RADLY Raia Drogasil SA ADR

N/A

USD 4.65B
SHPPF Shop Apotheke Europe N.V

N/A

USD 2.98B
SAEYY Shop Apotheke Europe N.V

-1.89 (-14.10%)

USD 2.96B
NOTR Nowtransit Inc

N/A

USD 0.57B
ZRSEF Zur Rose Group AG

N/A

USD 0.30B
RLLVF Relevium Technologies Inc

N/A

USD 5.28M

ETFs Containing BLMH

N/A

Market Performance

  Market Performance vs. Industry/Classification (Pharmaceutical Retailers) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 44.44% 94% A 82% B
Dividend Return N/A N/A N/A N/A N/A
Total Return 44.44% 94% A 82% B
Trailing 12 Months  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 3.14% 56% F 50% F
Dividend Return 3.14% 56% F 46% F
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 9.51% 100% F 96% N/A
Risk Adjusted Return 33.02% 88% B+ 73% C
Market Capitalization 0.01B 55% F 40% F

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

Low volatility

The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

What to not like:
Negative cashflow

The company had negative total cash flow in the most recent four quarters.

Overpriced on free cash flow basis

The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.